Atherosclerosis Prediction with High Sensitivity C-Reactive Protein (hs-CRP) and Related Risk Factor in Patient with Dyslipidemia
- PMID: 32127998
- PMCID: PMC7048367
- DOI: 10.3889/oamjms.2019.526
Atherosclerosis Prediction with High Sensitivity C-Reactive Protein (hs-CRP) and Related Risk Factor in Patient with Dyslipidemia
Abstract
Background: Inflammation plays a major role in the initiation, destabilization and the progression of atherosclerosis. High Sensitivity C-Reactive Protein (hs-CRP) reflects active systemic inflammation and have shown to be a strong predictor of future cardiovascular events.
Aim: The purpose of this study was to determine the role of High Sensitivity C-Reactive Protein (hs-CRP) independent for atherosclerosis severity prediction and to find out which factors largely is affecting hs-CRP level in dyslipidemia patient.
Methods: A total of 388 patients (267 dyslipidemia, 121 controls) were enrolled in this study. We investigated whether plasma hs-CRP is associated with atherosclerosis severity that was quantified by ankle-brachial index (ABI) and Doppler ultrasound. Related risk factor that influence hs-CRP levels in patients with dyslipidemia included determination of age, gender, diabetes, smoking, hypertension, total cholesterol, TG, LDL, HDL, and fasting glucose.
Results: Data showed a significant association between hs-CRP concentration level and the severity of atherosclerosis (p < 0.01). Univariate analysis showed that fasting plasma glucose, triglyceride, and BMI were significantly positively correlated with hs-CRP levels. Whereas, HDL cholesterol was negatively correlated with hs-CRP levels. Multivariate regression analysis using model 1 and 2, showed that in determining hs-CRP levels, triglyceride and BMI were taking a big role.
Conclusion: Hs-CRP correlates with extent of atherosclerosis, and high triglyceride and BMI is closely associated with high hs-CRP levels in patients with dyslipidemia.
Keywords: Atherosclerosis; Dyslipidemia; Hs-CRP.
Copyright: © 2019 Dewa Ayu Swastini, Ida Ayu Dewi Wiryanthini, Ni Luh Putu Ariastuti, Agus Muliantara.
References
-
- Hajilooi M. Ghanbili. Other Systemic Responses to Inflammation. The New J. Evaluation of C-Reactive Protein, a Sensitive Marker. England Journal of Medicine. 1999;340(6):448–454. https://doi.org/10.1056/NEJM199902113400607 PMid:9971870. - PubMed
-
- Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 2003;169(2):203–14. https://doi.org/10.1016/S0021-9150(03)00012-1. - PubMed
-
- Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis. Circulation. 2001;103(9):1194–7. https://doi.org/10.1161/01.CIR.103.9.1194 PMid:11238260. - PubMed
-
- Emerging Risk Factors Collaboration. C-reactive protein, fibrinogen, and cardiovascular disease prediction. NEnglJMed. 2012;367(14):1310–20. https://doi.org/10.1056/NEJMoa1107477 PMid:23034020 PMCid:PMC3714101. - PMC - PubMed
-
- Fonseca FA, Izar MC. High-sensitivity C-reactive protein and cardiovascular disease across countries and ethnicities. Clinics. 2016;71(4):235–42. https://doi.org/10.6061/clinics/2016(04)11. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous